MicroRNAs and atherosclerosis.

Julio Madrigal-Matute, Noemi Rotllan, Juan F. Aranda, Carlos Fernández-Hernando

Research output: Contribution to journalReview article

84 Citations (Scopus)

Abstract

MicroRNAs (miRNAs) are small, ~22 nucleotide (nt) sequences of RNA that regulate gene expression at posttranscriptional level. These endogenous gene expression inhibitors were primarily described in cancer but recent exciting findings have also demonstrated a key role in cardiovascular diseases (CVDs), including atherosclerosis. MiRNAs control endothelial cell (EC), vascular smooth muscle cell (VSMC), and macrophage functions, and thereby regulate the progression of atherosclerosis. MiRNA expression is modulated by different stimuli involved in every stage of atherosclerosis, and conversely miRNAs modulates several pathways implicated in plaque development such as cholesterol metabolism. In the present review, we focus on the importance of miRNAs in atherosclerosis, and we further discuss their potential use as biomarkers and therapeutic targets in CVDs.

Original languageEnglish (US)
Number of pages1
JournalUnknown Journal
Volume15
Issue number5
DOIs
StatePublished - May 2013
Externally publishedYes

Fingerprint

MicroRNAs
Atherosclerosis
Gene expression
Cardiovascular Diseases
Macrophages
Endothelial cells
Biomarkers
Gene Expression
Metabolism
Muscle
Nucleotides
Cholesterol
Vascular Smooth Muscle
Cells
RNA
Smooth Muscle Myocytes
Endothelial Cells
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Madrigal-Matute, J., Rotllan, N., Aranda, J. F., & Fernández-Hernando, C. (2013). MicroRNAs and atherosclerosis. Unknown Journal, 15(5). https://doi.org/10.1007/s11883-013-0322-z

MicroRNAs and atherosclerosis. / Madrigal-Matute, Julio; Rotllan, Noemi; Aranda, Juan F.; Fernández-Hernando, Carlos.

In: Unknown Journal, Vol. 15, No. 5, 05.2013.

Research output: Contribution to journalReview article

Madrigal-Matute, J, Rotllan, N, Aranda, JF & Fernández-Hernando, C 2013, 'MicroRNAs and atherosclerosis.', Unknown Journal, vol. 15, no. 5. https://doi.org/10.1007/s11883-013-0322-z
Madrigal-Matute, Julio ; Rotllan, Noemi ; Aranda, Juan F. ; Fernández-Hernando, Carlos. / MicroRNAs and atherosclerosis. In: Unknown Journal. 2013 ; Vol. 15, No. 5.
@article{e4b59a5c7162460f87eab20fc496f6b8,
title = "MicroRNAs and atherosclerosis.",
abstract = "MicroRNAs (miRNAs) are small, ~22 nucleotide (nt) sequences of RNA that regulate gene expression at posttranscriptional level. These endogenous gene expression inhibitors were primarily described in cancer but recent exciting findings have also demonstrated a key role in cardiovascular diseases (CVDs), including atherosclerosis. MiRNAs control endothelial cell (EC), vascular smooth muscle cell (VSMC), and macrophage functions, and thereby regulate the progression of atherosclerosis. MiRNA expression is modulated by different stimuli involved in every stage of atherosclerosis, and conversely miRNAs modulates several pathways implicated in plaque development such as cholesterol metabolism. In the present review, we focus on the importance of miRNAs in atherosclerosis, and we further discuss their potential use as biomarkers and therapeutic targets in CVDs.",
author = "Julio Madrigal-Matute and Noemi Rotllan and Aranda, {Juan F.} and Carlos Fern{\'a}ndez-Hernando",
year = "2013",
month = "5",
doi = "10.1007/s11883-013-0322-z",
language = "English (US)",
volume = "15",
journal = "Journal of Trace Elements in Medicine and Biology",
issn = "0946-672X",
publisher = "Urban und Fischer Verlag GmbH und Co. KG",
number = "5",

}

TY - JOUR

T1 - MicroRNAs and atherosclerosis.

AU - Madrigal-Matute, Julio

AU - Rotllan, Noemi

AU - Aranda, Juan F.

AU - Fernández-Hernando, Carlos

PY - 2013/5

Y1 - 2013/5

N2 - MicroRNAs (miRNAs) are small, ~22 nucleotide (nt) sequences of RNA that regulate gene expression at posttranscriptional level. These endogenous gene expression inhibitors were primarily described in cancer but recent exciting findings have also demonstrated a key role in cardiovascular diseases (CVDs), including atherosclerosis. MiRNAs control endothelial cell (EC), vascular smooth muscle cell (VSMC), and macrophage functions, and thereby regulate the progression of atherosclerosis. MiRNA expression is modulated by different stimuli involved in every stage of atherosclerosis, and conversely miRNAs modulates several pathways implicated in plaque development such as cholesterol metabolism. In the present review, we focus on the importance of miRNAs in atherosclerosis, and we further discuss their potential use as biomarkers and therapeutic targets in CVDs.

AB - MicroRNAs (miRNAs) are small, ~22 nucleotide (nt) sequences of RNA that regulate gene expression at posttranscriptional level. These endogenous gene expression inhibitors were primarily described in cancer but recent exciting findings have also demonstrated a key role in cardiovascular diseases (CVDs), including atherosclerosis. MiRNAs control endothelial cell (EC), vascular smooth muscle cell (VSMC), and macrophage functions, and thereby regulate the progression of atherosclerosis. MiRNA expression is modulated by different stimuli involved in every stage of atherosclerosis, and conversely miRNAs modulates several pathways implicated in plaque development such as cholesterol metabolism. In the present review, we focus on the importance of miRNAs in atherosclerosis, and we further discuss their potential use as biomarkers and therapeutic targets in CVDs.

UR - http://www.scopus.com/inward/record.url?scp=84883735147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883735147&partnerID=8YFLogxK

U2 - 10.1007/s11883-013-0322-z

DO - 10.1007/s11883-013-0322-z

M3 - Review article

C2 - 23512606

AN - SCOPUS:84883735147

VL - 15

JO - Journal of Trace Elements in Medicine and Biology

JF - Journal of Trace Elements in Medicine and Biology

SN - 0946-672X

IS - 5

ER -